CAM
NVO

Cidel Asset Management’s Novo Nordisk NVO Stock Holding History

Cidel Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-20,591
Closed -$1.77M – 356
2024
Q4 		$1.77M Sell
20,591
-1,312
-6% -$142K 0.12% 88
2024
Q3 		$2.61M Buy
21,903
+460
+2% +$61.3K 0.18% 77
2024
Q2 		$3.06M Buy
21,443
+12,875
+150% +$1.71M 0.24% 65
2024
Q1 		$1.1M Buy
+8,568
New +$1.02M 0.08% 106
2016
Q4 		– Sell
-31,114
Closed -$647K – 87
2016
Q3 		$647K Sell
31,114
-71,634
-70% -$1.78M 0.04% 55
2016
Q2 		$2.76M Sell
102,748
-3,084
-3% -$84.6K 0.16% 44
2016
Q1 		$2.87M Sell
105,832
-2,464
-2% -$66K 0.17% 43
2015
Q4 		$3.15M Sell
108,296
-22,048
-17% -$610K 0.2% 42
2015
Q3 		$3.54M Sell
130,344
-1,494
-1% -$42.3K 0.22% 45
2015
Q2 		$3.61M Sell
131,838
-13,100
-9% -$368K 0.16% 48
2015
Q1 		$3.87M Buy
144,938
+9,568
+7% +$220K 0.2% 50
2014
Q4 		$2.84M Buy
+135,370
New +$3.02M 0.13% 55

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Cidel Asset Management's NVO Position: Q1 2025 in Review

Cidel Asset Management sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 20,591 shares — an estimated $1.77M sold.

Cidel Asset Management first reported a position in NVO in Q4 2014 and held it in 12 quarters. The position peaked at $3.87M in Q1 2015. 1,528 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • Cidel Asset Management reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • Cidel Asset Management sold 20,591 Novo Nordisk shares in Q1 2025, an estimated $1.77M.
  • Cidel Asset Management first reported a position in Novo Nordisk in Q4 2014 and held it in 12 quarters.
  • Cidel Asset Management's Novo Nordisk position peaked at $3.87M in Q1 2015.
  • 1,528 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Cidel Asset Management's 13F filing for Q1 2025, filed 28 Apr 2025.